Inicio / Farmacia hospitalaria / Abstracts de farmacia hospitalaria / Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study

Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study

0 / 5 (0 votos)
Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study

International Journal of Clinical Pharmacy

First published:  27 December 2017
DOI: https://doi.org/10.1007/s11096-017-0578-4

Noh, Y., Lee, J., Shin, S. et al. Int J Clin Pharm 

Objective: To determine the effect of cilostazol in combination with ACEI or ARB treatment on the decline in eGFR. Setting A tertiary hospital in Korea. 

Methods: In an observational cohort study, we analyzed 5505 patients who were prescribed ACEI or ARB and cilostazol or other antiplatelet agents. 

SEGUIR LEYENDO

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.